Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Stanford Sinus Center is a specialized clinical and research entity within Stanford Health Care, dedicated to the treatment of advanced sinonasal and skull base disorders. The center is recognized globally for its expertise in endoscopic sinus surgery and the management of refractory chronic rhinosinusitis. It serves as a major hub for clinical trials evaluating novel therapeutic modalities, including biologics such as monoclonal antibodies for nasal polyps. Patients benefit from a multidisciplinary care model that integrates rhinology, neurosurgery, and allergy and immunology. The center also leads significant academic efforts in developing surgical innovations and investigating the pathophysiology of inflammatory airway diseases. Its mission encompasses high-level patient care, cutting-edge research, and the training of future leaders in the field of rhinology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stanford Sinus Center.